The World Health Organisation has declared a public health emergency of continental security as a previously rare strain of Ebola—Bundibugyo—spreads across eastern Democratic Republic of Congo with alarming scale and speed. Unlike previous outbreaks, this variant has no authorised vaccine, leaving health workers scrambling to contain a virus that kills a significant proportion of those it infects.
The Bundibugyo strain, first identified in 2007 in the DRC's Bundibugyo district, has re-emerged in a region already battered by conflict, displacement and a crumbling health infrastructure. Congolese health authorities confirmed that the current outbreak has produced hundreds of suspected cases, with a case fatality rate that health officials describe as deeply concerning. Unlike the well-documented Zaire strain that spurred the development of rVSV-ZEBOV vaccines, Bundibugyo has no equivalent preventive weapon.
We are fighting a virus we do not fully understand in a population that has already been through immense suffering, said a senior health official in Goma who requested anonymity due to the sensitivity of the situation. The absence of a licensed vaccine means we are relying on contact tracing, isolation and basic supportive care—tools that are proving insufficient in the face of this transmission speed.
Uganda, which shares a porous border with the DRC, has already deployed emergency measures. Authorities in Kampala have banned handshakes—part of a broader package of social distancing guidelines designed to interrupt person-to-person transmission. The country's health ministry has quarantined more than one hundred people who came into contact with suspected cases crossing the border. The U.S. Embassy in Kampala suspended visa services, citing the outbreak's geographic spread as a rationale for reducing foot traffic at its facilities.
The Africa Centres for Disease Control and Prevention convened an emergency session to coordinate a continental response. Several member states have issued travel advisories for the affected regions, and cross-border surveillance teams have been activated along the DRC-Uganda and DRC-Rwanda borders. Rwanda has already tightened health screenings at border points and restricted movement in districts closest to the outbreak zone.
What makes this outbreak particularly alarming is the confluence of factors amplifying its spread. The affected region of eastern DRC hosts large camps for internally displaced persons, where overcrowding and limited access to clean water make hygiene-based interventions extraordinarily difficult. Many communities in these areas have deep mistrust of health workers following years of conflict involving multiple armed groups, meaning that community engagement—the cornerstone of any Ebola response—faces serious obstacles.
The WHO's emergency committee has called for accelerated research into therapeutics effective against the Bundibugyo strain. Some experimental monoclonal antibody cocktails have shown activity against the strain in laboratory settings, but no clinical trials have been completed in the affected region. Global health advocates are calling on pharmaceutical companies to fast-track trials, warning that without international coordination, this outbreak could extend well into 2027.
For millions living in the shadow of this outbreak, the fear is visceral. In markets and displacement camps across North Kivu and Ituri provinces, conversations are dominated by rumours—some accurate, some not—about the virus's behaviour. Health workers on the ground describe a population that has been through too much already. Ebola has tortured us, one local medic told reporters. We know what this means. We know what it does.
As the death toll climbs past one hundred and the geographic footprint of the outbreak expands, the international community faces a test of whether the lessons of 2014, 2018, and 2020 were truly learned—or simply remembered.